The expression of APOE was also examined in the pre-treatment puncture samples of 19 carcinoma patients having received clinical αPD-1 treatment, and as revealed from the results, the expression of APOE in the αPD-1 resistant group significantly exceeded that in the αPD-1 sensitive group. This evidence concerns the gene APOE and carcinoma.